Company Interview / CSL leads the trading stakes in August

Key points:

August saw high trading volumes in ASX stocks on Stake, led by CSL (ASX:CSL) Woolworths (ASX:WOW) attracted significant buy orders despite post-earnings declines Many investors took profits in Qantas (ASX:QAN) after the stock hit new highs Activity in US stocks shifted towards individual big tech names and UnitedHealth (NYSE:UNH) after Berkshire Hathaway’s investment

August delivered a surge in trading volumes on Stake, especially across ASX-listed stocks, according to Samy Sriram of Stake. Sriram notes a heightened investor focus following reporting season, which drove strong moves in major names. CSL (ASX:CSL) accounted for 15% of all Stake trades in August, driven by its earnings report and restructuring announcement. Despite weak guidance and a price dip, about 90% of the subsequent orders were buys, typically via limit orders near $228 a sign, Sriram suggests, that investors are eyeing CSL for long-term exposure at an appealing valuation.

Woolworths Group (ASX:WOW) also experienced price weakness post-earnings, yet Sriram points out that robust buy-side conviction emerged around the $28 to $29 level. In contrast, Coles (ASX:COL) saw gains but less enthusiastic accumulation. This trend indicates investor preference for Woolworths, with expectations it might recover lost market share over time.

Qantas (ASX:QAN) has seen a different approach, according to Sriram, with many investors taking profits after recent highs, 60% of Stake trades following results were sells. On the US side, Sriram highlights a pivot away from index ETFs towards large-cap tech names such as Nvidia (NASDAQ:NVDA), Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Meta (NASDAQ:META), Tesla (NASDAQ:TSLA), Amazon (NASDAQ:AMZN), and UnitedHealth (NYSE:UNH), the latter surging after Berkshire Hathaway’s $1.6 billion stake was revealed.